SCHEMBL22018238

SCHEMBL22018238

O=C(Nc1cnc2[nH]ncc2c1C1CCCCCCC1)C1CCCCCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 3/20 0.46
CCNA2 P20248 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
ALOX15 P16050 1/20 0.43
HTT P42858 1/20 0.43
POLB P06746 1/20 0.43
GSK3B P49841 4/20 0.42
PIK3CD O00329 3/20 0.42
PIM1 P11309 3/20 0.42
PIK3CA P42336 3/20 0.42
PIK3CG P48736 2/20 0.42
CCNT1 O60563 2/20 0.42
CDK9 P50750 2/20 0.42
PIK3CB P42338 2/20 0.41
JAK3 P52333 1/20 0.41
ABL1 P00519 1/20 0.41
STK17B O94768 1/20 0.41
AAK1 Q2M2I8 1/20 0.41
PIK3C3 Q8NEB9 1/20 0.40
CETP P11597 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20368675 1.00 CDK2 (0.46) CDK2CCNA2SMN1; SMN2ALOX15HTT
SCHEMBL25564715 1.00 CDK2 (0.46) CDK2CCNA2SMN1; SMN2ALOX15HTT
SCHEMBL21157774 1.00 CDK2 (0.46) CDK2CCNA2SMN1; SMN2ALOX15HTT
SCHEMBL22138634 0.90 TNKS (0.45) CDK2CCNA2GSK3BCDK9JAK3
SCHEMBL22018234 0.81 JAK3 (0.49) CDK2JAK3STK17BAAK1CETP
SCHEMBL22853575 0.81 JAK3 (0.49) CDK2JAK3STK17BAAK1CETP
SCHEMBL20368735 0.81 JAK3 (0.49) CDK2JAK3STK17BAAK1CETP
SCHEMBL19059603 0.79 GSK3B (0.55) CDK2CCNA2GSK3BPIK3CDPIM1
SCHEMBL20368669 0.78 MALT1 (0.53) SMN1; SMN2HTTPOLBCETPHDAC3
SCHEMBL21157256 0.78 MALT1 (0.53) SMN1; SMN2HTTPOLBCETPHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2020-11-10 US disclosed
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE HOLDINGS CORPORATION 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM2, PIM1, PIM3 CDK2 67/4885CCNA2 1599/4885SMN1; SMN2 3837/4885
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors PIM2, PIM1, PIM3 CDK2 67/4885CCNA2 1599/4885SMN1; SMN2 3837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.